Applying the Retro-Enantio Approach To Obtain a Peptide Capable of Overcoming the Blood-Brain Barrier

Retro-Inverso Isomer of Angiopep-2: A Stable d-Peptide Ligand Inspires Brain-Targeted Drug Delivery

(2014) Xiaoli Wei et al.   MOLECULAR PHARMACEUTICS

In vivo temporal and spatial profile of leukocyte adhesion and migration after experimental traumatic brain injury in mice

(2013) Susanne M Schwarzmaier et al.   Journal of Neuroinflammation

Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor

(2012) Roger Prades et al.   BIOMATERIALS

Shuttle-Mediated Drug Delivery to the Brain

(2011) Morteza Malakoutikhah et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells

(2011) Megumi Kawamoto et al.   BMC CANCER

Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors

(2011) Yasuo Uchida et al.   JOURNAL OF NEUROCHEMISTRY

Engineering biofunctional magnetic nanoparticles for biotechnological applications

(2010) Maria Moros et al.   Nanoscale

Quaternary Ammonium β-Cyclodextrin Nanoparticles for Enhancing Doxorubicin Permeability across the In Vitro Blood−Brain Barrier

(2009) Eun Seok Gil et al.   BIOMACROMOLECULES

Retro-Enantio N-Methylated Peptides as β-Amyloid Aggregation Inhibitors

(2009) Dolors Grillo-Bosch et al.   ChemMedChem

An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening

(2008) Maxime Culot et al.   TOXICOLOGY IN VITRO